Intelligent Bio Solutions Inc. (INBS) stock
INBSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3058% below fair value
$1.51−0.03 (-1.95%)
Close on Nov 19, 2026Market cap $4.57MP/E –Yield –
Intelligent Bio Solutions free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Intelligent Bio Solutions's free cash flow for the twelve months ending Jun 30, 2026 was -$12.05M. For fiscal 2026 it was -$12.05M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$12.05M | – |
| FY2025 | Jun 30, 2025 | -$9.91M | – |
| FY2024 | Jun 30, 2024 | -$9.79M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -$3.18M | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$4.32M | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$1.64M | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -$2.92M | – |
See a number that looks wrong?